Learning Strategies for Improving Dual Task Performance in Multiple Sclerosis (StraDiMS)

September 1, 2021 updated by: Peter Feys, Hasselt University

This study is a randomized controlled study in which we aim to include 60 persons with Multiple Sclerosis and 30 healthy controls. Two different learning strategies, an explicit and an implicit one, will be compared on effects on dual task performance. Further, clinical profile associated with these effects, and brain activity measured by functional near-infrared spectroscopy during dual tasking will be investigated.

To this end, the study will cover 4 days:

Day 1: examine clinical profile; Day 2: baseline dual task measures; Day 3: experimental learning paradigm with subjects randomly assigned to either the implicit or the explicit learning condition.

Day 4: delayed retention dual task and fNIRS measures.

Study Overview

Study Type

Interventional

Enrollment (Actual)

37

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Overpelt, Belgium, 3900
        • Noorderhart
      • Steenokkerzeel, Belgium, 1820
        • National MS Center Melsbroek

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • all participants: minimal cognitive function (MoCA ≥ 26)
  • Persons with MS:

    • Diagnosis of MS
    • EDSS 2.0 - 5.5
    • No relapse within the past 30 days.
    • Able to walk minimally 6 minutes consecutively and to step over the stepping platform without aid.

Exclusion Criteria:

  • Other medical conditions interfering with mobility.
  • Other neurological conditions.
  • Not able to understand instructions.
  • Major (unresolvable) problems with hearing or vision.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: MS group implicit
participants perform a goal-directed stepping task and try to react as fast as possible by stepping on a tile that lights up. Response time (the time between the tile lighting up and the participant stepping on the tile) is the outcome measure of the task. The implicit learning conditions and the explicit learning condition differ from each other in the instructions given prior to the task. The latter group will get more knowledge on the task than the former.
EXPERIMENTAL: MS group explicit
participants perform a goal-directed stepping task and try to react as fast as possible by stepping on a tile that lights up. Response time (the time between the tile lighting up and the participant stepping on the tile) is the outcome measure of the task. The implicit learning conditions and the explicit learning condition differ from each other in the instructions given prior to the task. The latter group will get more knowledge on the task than the former.
ACTIVE_COMPARATOR: HC group implicit (Healthy Controls)
participants perform a goal-directed stepping task and try to react as fast as possible by stepping on a tile that lights up. Response time (the time between the tile lighting up and the participant stepping on the tile) is the outcome measure of the task. The implicit learning conditions and the explicit learning condition differ from each other in the instructions given prior to the task. The latter group will get more knowledge on the task than the former.
ACTIVE_COMPARATOR: HC group explicit (Healthy controls)
participants perform a goal-directed stepping task and try to react as fast as possible by stepping on a tile that lights up. Response time (the time between the tile lighting up and the participant stepping on the tile) is the outcome measure of the task. The implicit learning conditions and the explicit learning condition differ from each other in the instructions given prior to the task. The latter group will get more knowledge on the task than the former.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dual task (STEP + substraction sevens)
Time Frame: day 2
participants will step as fast as possible on a tile that lights up in a goal-directed stepping task on a platform consisting of 21 stepping tiles. Concurrently, they will perform a cognitive task in which they continuously subtract sevens, starting from a 3-digit given start number. Duration of the task depends on the speed of the participant (42 steps).
day 2
Dual task (STEP + substraction sevens)
Time Frame: day 4
participants will step as fast as possible on a tile that lights up in a goal-directed stepping task on a platform consisting of 21 stepping tiles. Concurrently, they will perform a cognitive task in which they continuously subtract sevens, starting from a 3-digit given start number. Duration of the task depends on the speed of the participant (42 steps).
day 4
Dual task (STEP + phonetic word list generation)
Time Frame: day 2
participants will step as fast as possible on a tile that lights up in a goal-directed stepping task on a platform consisting of 21 stepping tiles. Concurrently, they will perform a cognitive task in which they try to come up with as many words as possible starting with a given letter. Duration of the task depends on the speed of the participant (42 steps).
day 2
Dual task (STEP + phonetic word list generation)
Time Frame: day 4
participants will step as fast as possible on a tile that lights up in a goal-directed stepping task on a platform consisting of 21 stepping tiles. Concurrently, they will perform a cognitive task in which they try to come up with as many words as possible starting with a given letter. Duration of the task depends on the speed of the participant (42 steps).
day 4
Dual task (STEP + Auditory vigilance)
Time Frame: day 2
participants will step as fast as possible on a tile that lights up in a goal-directed stepping task on a platform consisting of 21 stepping tiles. Concurrently, they will perform a cognitive task in which they hear a string of letters (1 every 2.5 seconds) and are asked to respond as quickly as possible when they hear the target letter 'L' or 'R'. Duration of the task depends on the speed of the participant (42 steps).
day 2
Dual task (STEP + Auditory vigilance)
Time Frame: day 4
participants will step as fast as possible on a tile that lights up in a goal-directed stepping task on a platform consisting of 21 stepping tiles. Concurrently, they will perform a cognitive task in which they hear a string of letters (1 every 2.5 seconds) and are asked to respond as quickly as possible when they hear the target letter 'L' or 'R'. Duration of the task depends on the speed of the participant (42 steps).
day 4
Dual Task (WALK + Subtraction sevens)
Time Frame: day 2
participants will walk on their comfortable, preferred walking speed on a 30-meter walkway. Concurrently, they will perform a cognitive task in which they continuously subtract sevens, starting from a 3-digit given start number. Duration of the task is 30 seconds.
day 2
Dual Task (WALK + Subtraction sevens)
Time Frame: day 4
participants will walk on their comfortable, preferred walking speed on a 30-meter walkway. Concurrently, they will perform a cognitive task in which they continuously subtract sevens, starting from a 3-digit given start number. Duration of the task is 30 seconds.
day 4
Dual Task (WALK + Word list generation (phonetic)
Time Frame: day 2
participants will walk on their comfortable, preferred walking speed on a 30-meter walkway. Concurrently, they will perform a cognitive task in which they try to come up with as many words as possible starting with a given letter. Duration of the task is 30 seconds.
day 2
Dual Task (WALK + Word list generation (phonetic)
Time Frame: day 4
participants will walk on their comfortable, preferred walking speed on a 30-meter walkway. Concurrently, they will perform a cognitive task in which they try to come up with as many words as possible starting with a given letter. Duration of the task is 30 seconds.
day 4
Dual Task (WALK + Auditory vigilance)
Time Frame: day 2
participants will walk on their comfortable, preferred walking speed on a 30-meter walkway. Concurrently, they will perform a cognitive task in which they hear a string of letters (1 every 2.5 seconds) and are asked to respond as quickly as possible when they hear the target letter 'L' or 'R'. Duration of the task is 30 seconds.
day 2
Dual Task (WALK + Auditory vigilance)
Time Frame: day 4
participants will walk on their comfortable, preferred walking speed on a 30-meter walkway. Concurrently, they will perform a cognitive task in which they hear a string of letters (1 every 2.5 seconds) and are asked to respond as quickly as possible when they hear the target letter 'L' or 'R'. Duration of the task is 30 seconds.
day 4
learning measure
Time Frame: Day 3
participants will step as fast as possible on a tile that lights up in a goal-directed stepping task on a platform consisting of 21 stepping tiles. The outcome measure on this task is response time (time from the moment the tile lights up, until the participant steps on the tile).
Day 3
fNIRS measure (functional near-infrared spectroscopy)
Time Frame: day 4
a block-design test with 3 tasks (cognitive ST, motor ST and DT) of 25 seconds per task-block (repeated 5 times) will be conducted with a functional near-infrared spectroscopy (fNIRS) neuroimaging system to measure hemoglobin changes during performance of the task and compared between single task and dual task conditions and between groups. Besides, fNIRS will be used during 1 task related to the learning-paradigm.
day 4

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
weight
Time Frame: day 1
day 1
Age
Time Frame: day 1
day 1
height
Time Frame: day 1
day 1
educational level questionnaire
Time Frame: day 1
day 1
date of diagnosis questionnaire
Time Frame: day 1
day 1
type of MS questionnaire
Time Frame: day 1
day 1
EDSS
Time Frame: day 1
Expanded Disability Status Scale (EDSS)
day 1
Digit span forwards visually
Time Frame: day 1
day 1
Brief Visuospatial Memory Test (BVMT)
Time Frame: day 1
day 1
10/36 Spatial Recall test (SPART)
Time Frame: day 1
day 1
Symbol Digit Modalities Test (SDMT)
Time Frame: day 1
day 1
Paced Auditory Serial Addition Test (PASAT)-3 seconds
Time Frame: day 1
day 1
Digit Span backwards auditory
Time Frame: day 1
day 1
6 minute walking test (6MWT)
Time Frame: day 1
day 1
Timed-Up and Go (TUG)
Time Frame: day 1
day 1
Timed 25 Foot Walk (T25FW)
Time Frame: day 1
day 1
4 square stepping test (FSST)
Time Frame: day 1
day 1
Berg Balance Scale (BBS)
Time Frame: day 1
day 1
Tandem Walk 3m
Time Frame: day 1
day 1
Motricity Index
Time Frame: day 1
day 1
Movement specific reinvestment scale (MSRS)
Time Frame: day 1
day 1
MS Neuropsychological screening questionnaire (MSNQ)
Time Frame: day 1
day 1
Multiple Sclerosis Walking Scale (MSWS-12)
Time Frame: day 1
day 1
Modified fatigue impact scale (MFIS)
Time Frame: day 1
day 1
Activities-specific Balance Confidence scale (ABC)
Time Frame: day 1
day 1
Dual Task Questionnaire (DTQ)
Time Frame: day 1
day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2020

Primary Completion (ACTUAL)

April 30, 2021

Study Completion (ACTUAL)

April 30, 2021

Study Registration Dates

First Submitted

August 31, 2020

First Submitted That Met QC Criteria

September 3, 2020

First Posted (ACTUAL)

September 4, 2020

Study Record Updates

Last Update Posted (ACTUAL)

September 2, 2021

Last Update Submitted That Met QC Criteria

September 1, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Sclerosis

Clinical Trials on StraDiMS implicit

3
Subscribe